Literature DB >> 11117961

UK measles outbreak in non-immune anthroposophic communities: the implications for the elimination of measles from Europe.

B Hanratty1, T Holt, E Duffell, W Patterson, M Ramsay, J M White, L Jin, P Litton.   

Abstract

We describe the epidemiology of the first nationwide outbreak of measles infection in the UK since the implementation of a mass vaccination campaign. Notifications of infectious diseases, interview and postal questionnaire identified 293 clinical cases, 138 of which were confirmed by salivary IgM, measles virus isolation and PCR. Twelve were epidemiologically linked to confirmed cases. The outbreak began in London, after contact with measles infection probably imported from Italy. Measles genotyping determined by sequence analysis confirmed spread to other unimmunized anthroposophic communities in the north, south west and south coast of England. Only two cases had been vaccinated against measles infection, and 90% of cases were aged under 15 years. Measles virus can selectively target non-immune groups in countries with high vaccine uptake and broader herd immunity. Without harmonization of vaccination policies and uniform high coverage across Europe, the importation and spread of measles virus amongst non-immune groups may prevent the elimination of measles.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11117961      PMCID: PMC2869610          DOI: 10.1017/s0950268899004525

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  17 in total

1.  Attitudes of parents towards measles and immunisation after a measles outbreak in an anthroposophical community.

Authors:  E Duffell
Journal:  J Epidemiol Community Health       Date:  2001-09       Impact factor: 3.710

Review 2.  Modelling the influence of human behaviour on the spread of infectious diseases: a review.

Authors:  Sebastian Funk; Marcel Salathé; Vincent A A Jansen
Journal:  J R Soc Interface       Date:  2010-05-26       Impact factor: 4.118

3.  Networks of influence and infection: parental choices and childhood disease.

Authors:  Ken T D Eames
Journal:  J R Soc Interface       Date:  2009-05-15       Impact factor: 4.118

4.  MMR: marginalised, misrepresented and rejected? Autism: a focus group study.

Authors:  Shona Hilton; Kate Hunt; Mark Petticrew
Journal:  Arch Dis Child       Date:  2007-04       Impact factor: 3.791

5.  Measles outbreaks affecting children in Jewish ultra-orthodox communities in Jerusalem.

Authors:  C Stein-Zamir; G Zentner; N Abramson; H Shoob; Y Aboudy; L Shulman; E Mendelson
Journal:  Epidemiol Infect       Date:  2007-04-16       Impact factor: 2.451

6.  A ferret model of canine distemper virus virulence and immunosuppression.

Authors:  Veronika von Messling; Christoph Springfeld; Patricia Devaux; Roberto Cattaneo
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

7.  Participation in and attitude towards the national immunization program in the Netherlands: data from population-based questionnaires.

Authors:  Liesbeth Mollema; Nancy Wijers; Susan J M Hahné; Fiona R M van der Klis; Hendriek C Boshuizen; Hester E de Melker
Journal:  BMC Public Health       Date:  2012-01-20       Impact factor: 3.295

8.  Quantifying the impact of mass vaccination programmes on notified cases in the Netherlands.

Authors:  M van Wijhe; A D Tulen; H Korthals Altes; S A McDonald; H E de Melker; M J Postma; J Wallinga
Journal:  Epidemiol Infect       Date:  2018-03-14       Impact factor: 4.434

9.  Molecular epidemiology of measles virus in Italy, 2002-2007.

Authors:  Fabio Magurano; Claudia Fortuna; Antonella Marchi; Eleonora Benedetti; Paola Bucci; Melissa Baggieri; Loredana Nicoletti
Journal:  Virol J       Date:  2012-11-23       Impact factor: 4.099

10.  Immunopathogenic and neurological mechanisms of canine distemper virus.

Authors:  Otávio Valério Carvalho; Clarisse Vieira Botelho; Caroline Gracielle Torres Ferreira; Paulo Oldemar Scherer; Jamária Adriana Pinheiro Soares-Martins; Márcia Rogéria Almeida; Abelardo Silva Júnior
Journal:  Adv Virol       Date:  2012-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.